Impax Laboratories to Present at the 2014 Credit Suisse Healthcare Conference on November 11

HAYWARD, Calif., Nov. 10 2014 /PRNewswire/ -- Impax Laboratories, Inc. IPXL invites investors and the general public to listen to a webcast of a discussion with Fred Wilkinson, President and CEO at the Credit Suisse Healthcare Conference on Tuesday, November 11, at 1:00 p.m. Mountain Standard Time. The conference will be held in Scottsdale, AZ.

To listen to the live or archived webcast, visit the investor relations section of the Company's web site at http://investors.impaxlabs.com.  This presentation will be archived on the Company's web site for 30 days.

About Impax Laboratories, Inc.

Impax Laboratories, Inc. (Impax) is a technology based specialty pharmaceutical company applying its formulation expertise and drug delivery technology to the development of controlled-release and specialty generics in addition to the development of central nervous system disorder branded products. Impax markets its generic products through its Global Pharmaceuticals division and markets its branded products through the Impax Pharmaceuticals division. Additionally, where strategically appropriate, Impax develops marketing partnerships to fully leverage its technology platform and pursues partnership opportunities that offer alternative dosage form technologies, such as injectables, nasal sprays, inhalers, patches, creams and ointments. For more information, please visit the Company's Web site at: www.impaxlabs.com.

Company Contact:                                                  
Mark Donohue
Investor Relations and Corporate Communications      
(215) 558-4526                                                           
www.impaxlabs.com

Logo - http://photos.prnewswire.com/prnh/20140402/PH96035LOGO

SOURCE Impax Laboratories, Inc.